Validation of SAG/RBX2/ROC2 E3 ubiquitin ligase as an anticancer and radiosensitizing target.

Source:http://linkedlifedata.com/resource/pubmed/id/20103673

Clin. Cancer Res. 2010 Feb 1 16 3 814-24

Download in:

View as

General Info

PMID
20103673